Search Results - "Agrawal, Ritesh"

Renal Ultrasound Screening in Evaluation of Children with First Urinary Tract Infection by Mishra, Om P, Agrawal, Ritesh K

Get full text

Audit of stored strain energy and extent of future earthquake rupture in central Himalaya by Sreejith, K. M., Sunil, P. S., Agrawal, Ritesh, Saji, Ajish P., Rajawat, A. S., Ramesh, D. S.

“…The deadly 25 April 2015 Gorkha earthquake (M w  = 7.8) and aftershocks have partially released the accumulated interseismic strain along the Main Himalayan…”
Get full text

Medullary Infarction of Bilateral Tibia - A Rare Presentation of Tuberculosis: A Case Report with Review of Literature by Mishra, Arpita, Singh, Ashok, Agrawal, Ritesh, Mishra, Om

“…Background: Bony infarction or osteonecrosis is a rare, painful condition, reported in the setting of trauma, chronic steroid exposure, radiation,…”
Get full text

Semi-automatic extraction of land degradation processes using multi sensor data by applying object based classification technique by Raghubanshi, Sudhanshu, Agrawal, Ritesh, Rajawat, A. S., Rajak, D. Ram

“…A semi-automated method has been developed for the extraction of land degradation processes using multi sensor data by applying an object-based classification…”
Get full text

Next generation tyrosine kinase inhibitor (TKI): afatinib by Kumar, Suresh, Agrawal, Ritesh

“…Afatinib is a recently introduced new tyrosine kinase inhibitor, approved by the USFDA on July 12, 2013. Afatinib is marketed under the trade name Gilotrif and…”
Get more information

Indeterminate thyroid nodule: Mystery continues despite recent advances by Joshi, Ameya, Agrawal, Ritesh

Get full text

Linagliptin: a novel methylxanthin based approved dipeptidyl peptidase-4 inhibitor by Agrawal, Ritesh, Jain, Pratima, Dikshit, S N

“…Chemically, methylxanthine nucleus based Linagliptin (BI-1356, BI-1356-BS) is a dipeptidyl peptidase-IV inhibitor, which has been developed by Boehringer…”
Get more information

Echocardiographic evaluation of heart in chronic obstructive pulmonary disease patient and its co-relation with the severity of disease by Gupta, N K, Agrawal, Ritesh Kumar, Srivastav, A B, Ved, M L

“…Chronic obstructive pulmonary disease (COPD) has considerable effects on cardiac functions, including those of the right ventricle, left ventricle, and…”
Get full text

Apixaban: a new player in the anticoagulant class by Agrawal, Ritesh, Jain, Pratima, Dikshit, S N

“…Apixaban (BMS-562247-01) is a compound being investigated as an anticoagulant. Apixaban molecule is developed in a joint venture by Pfizer and Bristol-Myers…”
Get more information

The first approved agent in the Glitazar's Class: Saroglitazar by Agrawal, Ritesh

“…The new chemical entity (NCE) has been knocked as novel antidiabetic agent, e.g. Saroglitazar. Saroglitazar is a drug for the treatment of Type II diabetes…”
Get more information

Ligand-based pharmacophore detection, screening of potential gliptins and docking studies to get effective antidiabetic agents by Agrawal, Ritesh, Jain, Pratima, Dikshit, Subodh Narayan

“…Three-dimensional pharmacophore hypothesis was established based on a set of known DPP-IV inhibitor using PharmaGist software program understanding the…”
Get more information

3D QSAR and docking studies of various amido and benzyl-substituted 3-amino-4-(2-cyanopyrrolidide)pyrrolidinyl analogs as DPP-IV inhibitors by Agrawal, Ritesh, Jain, Pratima, Dikshit, Subodh Narayan, Jain, Sourabh

“…The article describes the development of a robust pharmacophore model and the investigation of structure activity relationship analysis of…”
Get more information

Clinical Presentation and Outcome of COVID-19 in Children: A Case Series by Agrawal, Ritesh Kumar, Pandey, Meenakshi, Singh, Ashok, Sanghvi, Nirali, Yadav, Kusumlata

“…The novel Coronavirus Disease 2019 (COVID-19) is an illness caused by Severe Acute Respiratory Syndrome 2 (SARS-CoV-2), which affects children as well as…”
Get full text

Novel serine protease dipeptidyl peptidase IV inhibitor: alogliptin by Agrawal, Ritesh, Bahare, Radhe Shyam, Jain, Pratima, Dikshit, Subodh Narayan, Ganguly, Swastika

“…Alogliptin (codenamed SYR-322) is a recently approved anti-diabetic drug in Japan, which has been under clinical development phase III in USA and Europe…”
Get more information

3D QSAR and docking study of gliptin derivatives as DPP-IV inhibitors by Agrawal, Ritesh, Jain, Pratima, Dikshit, Subodh Narayan, Bahare, Radhe Shyam

“…The article describes the development of a robust pharmacophore model and the investigation of structure activity relationship analysis of 46 xanthine…”
Get more information

Markers of oxidative stress in children with iron deficiency anemia by Yadav, Kusumlata, Mishra, Om P., Khandhadiya, Ketki, Mishra, Surendra P., Mishra, Arpita, Singh, Ashok, Agrawal, Ritesh K., Sanghvi, Nirali, Mishra, Akash

“…Oxidative stress can occur in iron deficiency anemia (IDA), causing cellular injury. The primary objective of the study was to assess serum malondialdehyde…”
Get full text

Cellular and molecular mechanisms of curcumin in prevention and treatment of disease by Patel, Sita Sharan, Acharya, Ashish, Ray, R. S., Agrawal, Ritesh, Raghuwanshi, Ramsaneh, Jain, Priyal

“…Curcumin is a naturally occurring polyphenolic compound present in rhizome of Curcuma longa belonging to the family zingiberaceae. Growing experimental…”
Get full text

Primary Hyperparathyroidism from Parathyroid Microadenoma by Agrawal, Ritesh, MS, Agarwal, Sudhi, MS, Mishra, Anjali, MS, Agarwal, Gaurav, MS, Agarwal, Amit, MS, Verma, Ashok K., MS, Mishra, Saroj K., MS, Chand, Gyan, MS

Get full text

Mixed type Ⅰ and Ⅱ choledochal cyst in an adult by Agarwal, Nitin, Kumar, Sunil, Hai, Abdul, Parfitt, Ritesh

“…BACKGROUND:Choledochal cysts are classified into five types based on the location of the cyst.Mixed types of choledochal cysts are extremely rare.Only five…”
Get full text

Oseltamivir: a first line defense against swine flu by Agrawal, Ritesh, Rewatkar, Prarthana V, Kokil, Ganesh R, Verma, Arunima, Kalra, Atin

“…Oseltamivir (has known by its brand name 'Tamiflu') is a prodrug, requiring ester hydrolysis for conversion to the active form, Oseltamivir carboxylate…”
Get more information